These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4037245)

  • 1. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues.
    Shuster JJ; Krischer JP; Boyett JM
    Am J Pediatr Hematol Oncol; 1985; 7(1):64-70. PubMed ID: 4037245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. I. A general overview.
    Shuster JJ; Krischer JP; Boyett JM
    Am J Pediatr Hematol Oncol; 1985; 7(1):57-63. PubMed ID: 4037244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.
    Gwede CK; Johnson DJ; Daniels SS; Trotti A
    J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some ethical issues in phase II trials in acute leukemia.
    Thall PF; Estey EH
    Clin Adv Hematol Oncol; 2005 Dec; 3(12):943-8. PubMed ID: 16555436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of toxicity: statistical considerations.
    Herson J
    Cancer Treat Rep; 1980; 64(2-3):463-8. PubMed ID: 7407785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical side of multistage clinical trials for screening new agents.
    Herson J
    Cancer Treat Rep; 1983 Jan; 67(1):71-5. PubMed ID: 6616494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and errors of clinical trials and the role and place of different types of trial.
    Mathé G; Reizenstein P
    Drugs Exp Clin Res; 1986; 12(1-3):1-9. PubMed ID: 3732046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring clinical trials: issues and controversies regarding confidentiality.
    Fleming TR; Ellenberg S; DeMets DL
    Stat Med; 2002 Oct; 21(19):2843-51. PubMed ID: 12325100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status and issues in clinical trials of anticancer agents].
    Kojima H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential clinical trials in cancer research.
    George SL
    Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designs for group sequential phase II clinical trials.
    Chang MN; Therneau TM; Wieand HS; Cha SS
    Biometrics; 1987 Dec; 43(4):865-74. PubMed ID: 3427171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesia and anesthesia for neonates: study design and ethical issues.
    Anand KJ; Aranda JV; Berde CB; Buckman S; Capparelli EV; Carlo WA; Hummel P; Lantos J; Johnston CC; Lehr VT; Lynn AM; Maxwell LG; Oberlander TF; Raju TN; Soriano SG; Taddio A; Walco GA
    Clin Ther; 2005 Jun; 27(6):814-43. PubMed ID: 16117988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conduct of therapeutic trials in cancer medicine.
    Rudnick S; Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):255-8. PubMed ID: 327556
    [No Abstract]   [Full Text] [Related]  

  • 17. Policies for interim analysis and interim reporting of results.
    O'Fallon JR
    Cancer Treat Rep; 1985 Oct; 69(10):1101-6. PubMed ID: 4042090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials symposium. Highlights in development of randomized clinical trials.
    Forbes JF
    Med J Aust; 1981 Feb; 1(4):159-60. PubMed ID: 6939955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.